Bank of America’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.82M Buy
128,048
+59,245
+86% +$1.94M ﹤0.01% 3504
2025
Q4
$2.07M Sell
68,803
-137,340
-67% -$3.89M ﹤0.01% 4033
2025
Q3
$5.41M Buy
206,143
+157,440
+323% +$3.75M ﹤0.01% 3918
2025
Q2
$1.04M Sell
48,703
-3,738
-7% -$84.3K ﹤0.01% 5280
2025
Q1
$1.11M Buy
52,441
+3,271
+7% +$67.1K ﹤0.01% 5145
2024
Q4
$996K Sell
49,170
-2,269
-4% -$46.9K ﹤0.01% 5034
2024
Q3
$864K Buy
+51,439
New +$867K ﹤0.01% 5146

Other funds holding GRDN

Bank of America's GRDN Position: Q1 2026 in Review

Bank of America increased its Guardian Pharmacy Services (GRDN) stake by 86% in Q1 2026, buying an estimated $1.94M and bringing the position to 128,048 shares worth $4.82M. The position accounts for ﹤0.01% of the portfolio, ranked #3504.

Bank of America first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.41M in Q3 2025. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Bank of America held 128,048 shares of Guardian Pharmacy Services worth $4.82M as of Q1 2026.
  • Bank of America bought 59,245 Guardian Pharmacy Services shares in Q1 2026, an estimated $1.94M.
  • Guardian Pharmacy Services made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3504 holding.
  • Bank of America first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • Bank of America's Guardian Pharmacy Services position peaked at $5.41M in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.